Secondaries Announced 2.26.18

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company: Bright Scholar Education Holdings Limited
Symbol: BEDU
Price: Last Trade $20.15
Trade Date: 3/1
Shares: 10 million
Underwriter(s): Deutsche Bank, Goldman Sachs (Asia)
Description: They are the largest operator of international and bilingual K-12 schools in China in terms of student enrollment as of September 1, 2017, according to the Frost & Sullivan report.
Rating = Subscription Needed

Company: InspireMD, Inc.
Symbol: NSPR
Price: Last Trade $3.86
Trade Date: TBD
Shares: 3.2 million
Re-Offer Range: Subscription Needed
Underwriter(s): H.C. Wainwright & Co.
Description: InspireMD seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.
Rating = Subscription Needed

Company: Tyme Technologies, Inc.
Symbol: TYME
Price: Last Trade $3.88
Trade Date: 3/1
Shares: 12 million
Underwriter(s): Evercore Group, Stifel, Canaccord
Description: Tyme Technologies, Inc. is a clinical-stage biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types while having a low toxicity profile.
Rating =Subscription Needed

Company: NMI Holdings, Inc.
Symbol: NMIH
Price: Last Trade $21.70
Trade Date: 2/28
Shares: 3.7 million
Underwriter(s): J.P. Morgan, Deutsche Bank Securities, RBC Capital Markets
Co-Manager(s): SunTrust Robinson Humphrey, Dowling & Partners Securities, Keefe Bruyette & Woods, Zelman Partners
Description: They are the parent company of National Mortgage Insurance Corporation (National MI), a U.S.-based, private mortgage insurance company enabling low down payment borrowers to realize home ownership while protecting lenders and investors against losses related to a borrower’s default.
Rating = Subscription Needed

Company: RA Pharmaceuticals – Block
Symbol: RARX
Price: Last Trade $6.71
Trade Date: 2/27
Shares: 0.5 million
Re-Offer Range: Subscription Needed
Underwriter(s): Morgan Stanley
Description: Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases.
Rating = Subscription Needed